Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

NCT06591910 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Stage III Non-small-cell Lung Cancer

Interventions

DRUG: Chemoimmunotherapy
PROCEDURE: Surgery
RADIATION: Radiation

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China